Myelodysplastic Syndromes and Myeloproliferative Neoplasms

CCO&rsquo s expert faculty review and share their expert perspectives on key findings in MDS and myeloproliferative neoplasms presented at the 2019 ASH annual meeting.

Share

Program Content

Activities

  • ASH 2019: MPN/MDS
    Advances in MDS and MPN From ASH 2019
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 09, 2020

    Expires: March 08, 2021

Activities

Luspatercept for Anemia in MF
Phase II Study: Luspatercept for Treatment of Myelofibrosis-Associated Anemia
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2019

Expires: December 06, 2020

MEDALIST: Luspatercept in MDS
Updated Analysis From the Phase III MEDALIST Trial of Luspatercept to Treat Anemia in Lower-Risk RBC Transfusion-Dependent MDS With Ring Sideroblasts
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2019

Expires: December 13, 2020

APR-246 + AZA in MDS/AML
Phase Ib/II Trial of APR-246 + Azacitidine in TP53-Mutant MDS and AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2019

Expires: December 17, 2020

TP53 Mutant MDS/AML: APR-246 + Aza
GFM Phase II Study of APR-246 Plus Azacitidine in TP53-Mutated MDS and AML
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 19, 2019

Expires: December 17, 2020

VEN ± AZA in MDS
Phase Ib Study: Venetoclax With or Without Azacitidine for Treatment of Relapsed/Refractory Myelodysplastic Syndrome
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Provided by

ProCE Banner

Supporters

AstraZeneca

Celgene

Dova Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Loxo Oncology subsidiary of Eli Lilly

Pharmacyclics an AbbVie Company